Taku Yoshida
Taku Yoshida publishes mostly in Immunology, Physiology and Molecular Biology, on topics such as Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Immune Cell Function and Interaction.
- World rank
- #1,708,442 of 7,710,434 ranked researchers
- Rank in Japan
- #28,900 of 383,136
- Works
- 125
- Citations
- 3.9k
- Citations per work
- 31.2
What does Taku Yoshida research?
Taku Yoshida's work is mostly in Medicine (23%), Immunology and Microbiology (14%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else6048.2%
- Life Sciences3628.4%
- Health Sciences2923.4%
- Medicine2923.4%
- 1Immunology14% of their works
- 2Physiology10% of their works
- 3Molecular Biology8% of their works
- 4Psychiatry and Mental health7% of their works
- 5Oncology7% of their works
- 6Neurology6% of their works
Research topics
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Cancer Immunotherapy and Biomarkers
- Diabetes and associated disorders
Which keywords describe Taku Yoshida's research?
The keywords of their largest research topics: Neurodegeneration, Neuroinflammation, Amyloid Hypothesis, Tau Pathology, Alzheimer's Disease, Mild Cognitive Impairment, Autoimmunity and Natural Killer Cells.
- Genetics
- Immune Checkpoint Blockade
- Microglia
- Astrocytes
- Foxp3
- NK Cell Recognition
- Mild Cognitive Impairment
- Tau Pathology
- Neuroinflammation
- Neurodegeneration
- Amyloid Hypothesis
- Alzheimer's Disease
- Autoimmunity
- Natural Killer Cells
- TGF-ß
- Cerebral Hypoperfusion
- Vascular Cognitive Impairment
- PD-1 and PD-L1
- Type 1 Diabetes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Neurodegeneration252 topics
- Neuroinflammation252 topics
- Amyloid Hypothesis181 topic
- Tau Pathology181 topic
- Alzheimer's Disease161 topic
- Mild Cognitive Impairment161 topic
- Autoimmunity132 topics
- NK Cell Recognition121 topic
- Natural Killer Cells121 topic
- Foxp381 topic
- TGF-ß81 topic
- Astrocytes71 topic
- Cerebral Hypoperfusion71 topic
- Microglia71 topic
- Vascular Cognitive Impairment71 topic
- Immune Checkpoint Blockade61 topic
- PD-1 and PD-L161 topic
- Genetics51 topic
- Type 1 Diabetes51 topic
Where does Taku Yoshida work?
Taku Yoshida's main affiliation in the publication record is Ehime University, Japan.
How many publications and citations does Taku Yoshida have?
OpenAlex counts 125 works and 3,899 citations for Taku Yoshida, an h-index of 28, ranking #1,708,442 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Taku Yoshida. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.